Article
Researchers from the Department of Dermatology, Massachusetts General Hospital, and Harvard Medical School in Boston administered twice-weekly 308-nm UV-B radiation to selected vitiligo lesions for a maximum of 60 treatments.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 2-7
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Topical Corticosteroids: Potency, Vehicles, and Best Practices